Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

BACKGROUND: Pivotal trials of COVID-19 vaccines did not include cancer patients with questions remaining in this population. Particularly in patients with thoracic malignancies receiving anticancer treatments, the safety of these vaccines has so far been little investigated. METHODS: This is a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitaleri, G., Trillo Aliaga, P., Catania, C., Signore, E. Del, Attili, I., Santoro, C., Giugliano, F., Berton Giachetti, P.P.M, Curigliano, G., Passaro, A., de Marinis, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584758/
https://www.ncbi.nlm.nih.gov/pubmed/36372676
http://dx.doi.org/10.1016/j.cllc.2022.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584758/
https://www.ncbi.nlm.nih.gov/pubmed/36372676
http://dx.doi.org/10.1016/j.cllc.2022.10.004

Ejemplares similares